Clinical Trials Directory

Trials / Terminated

TerminatedNCT01798316

IV Acetaminophen for Postoperative Analgesia

IV Acetaminophen for Postoperative Analgesia After Laparoscopic Cholecystectomy

Status
Terminated
Phase
Phase 4
Study type
Interventional
Enrollment
105 (actual)
Sponsor
Northwell Health · Academic / Other
Sex
All
Age
18 Years – 65 Years
Healthy volunteers
Not accepted

Summary

The purpose of this study is to evaluate the use of IV acetaminophen for postoperative pain management after laparoscopic cholecystectomy to determine if its use to supplement standard of care pain management decreases the incidence of post-operative nausea and vomiting.

Detailed description

The recent clinical development of an intravenous (IV) acetaminophen formulation for use in the US has important implications for the management of postoperative pain given its safety profile and suitability for use in the early phase of the postoperative period. In clinical studies a significant opioid-sparing effect has been documented with a substantial percentage of patients avoiding the need for opioid rescue medication altogether. This avoidance or delay in the use of opioids has been shown to reduce undesirable side effects. It is proposed that the use of IV acetaminophen in the post anesthesia care unit (PACU) for postoperative analgesia after laparoscopic cholecystectomy will result in decreased incidence of post operative nausea and vomiting (PONV) and decreased use of narcotics.

Conditions

Interventions

TypeNameDescription
DRUGIV AcetaminophenSingle dose, 1000g mg infusion over 15 minutes plus standard of care pain management regimen
DRUGStandard of CareStandard of care pain management regimen, no IV Acetaminophen,

Timeline

Start date
2013-03-01
Primary completion
2015-09-01
Completion
2015-09-01
First posted
2013-02-25
Last updated
2017-05-31
Results posted
2017-05-31

Locations

3 sites across 1 country: United States

Source: ClinicalTrials.gov record NCT01798316. Inclusion in this directory is not an endorsement.